FDAnews Device Daily Bulletin

CYBERONICS RAISES Q4 SALES GUIDANCE ON INCREASED DEMAND FOR VNS THERAPY

May 3, 2006
A A

Cyberonics Inc., a medical devices manufacturer, raised its outlook for fourth quarter sales on increased demand for VNS, or vagus nerve stimulation, therapy among treatment resistant-depression patients and psychiatrists. The company reiterated its guidance for fiscal year 2007. Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/240929/)